Mucosal immunization with DNA-liposome complexes

被引:76
作者
Klavinskis, LS [1 ]
Gao, LQ [1 ]
Barnfield, C [1 ]
Lehner, T [1 ]
Parker, S [1 ]
机构
[1] VICAL INC,SAN DIEGO,CA 92121
关键词
intranasal immunization; DNA-liposome; luciferase;
D O I
10.1016/S0264-410X(96)00278-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mucosal surfaces represent the primary site for transmission of several viruses including HIV. To prevent mucosal transmission and dissemination to the regional lymph nodes, an effective HIV vaccine may need to stimulate immune responses at the genital and rectal mucosa. Optimal induction of mucosal immunity in general requires targeting antigens to the specialized antigen presenting cells of mucosal associated lymphoid tissues. The nasal mucosa may provide a simple, non-invasive route to deliver DNA encoding the introduced gene to stimulate mucosal immunity. As a first step to evaluate the feasibility of this approach, we have investigated as a model system, systemic and mucosal immune responses elicited to firefly luciferase generated by DNA immunization. Incorporating DNA into liposomes with cationic lipids enhanced luciferase expression in nasal tissue, and was associated with induction of a humoral response in serum and vaginal fluids and also a proliferative and cytotoxic T lymphocyte response in the spleen and iliac lymph nodes draining the genital and rectal mucosa. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:818 / 820
页数:3
相关论文
共 11 条
[1]   NONINVASIVE LIPOSOME-MEDIATED GENE DELIVERY CAN CORRECT THE ION-TRANSPORT DEFECT IN CYSTIC-FIBROSIS MUTANT MICE [J].
ALTON, EWFW ;
MIDDLETON, PG ;
CAPLEN, NJ ;
SMITH, SN ;
STEEL, DM ;
MUNKONGE, FM ;
JEFFERY, PK ;
GEDDES, DM ;
HART, SL ;
WILLIAMSON, R ;
FASOLD, KI ;
MILLER, AD ;
DICKINSON, P ;
STEVENSON, BJ ;
MCLACHLAN, G ;
DORIN, JR ;
PORTEOUS, DJ .
NATURE GENETICS, 1993, 5 (02) :135-142
[2]   Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration [J].
Jones, DH ;
Corris, S ;
McDonald, S ;
Clegg, JCS ;
Farrar, GH .
VACCINE, 1997, 15 (08) :814-817
[3]   VACCINATION AND PROTECTION FROM A LETHAL VIRAL-INFECTION - IDENTIFICATION, INCORPORATION, AND USE OF A CYTOTOXIC LYMPHOCYTE-T GLYCOPROTEIN EPITOPE [J].
KLAVINSKIS, LS ;
WHITTON, JL ;
JOLY, E ;
OLDSTONE, MBA .
VIROLOGY, 1990, 178 (02) :393-400
[4]  
KLAVINSKIS LS, 1995, CLIN IMMUN IMMONOPAT, V76, P496
[5]  
KLAVINSKIS LS, 1995, CLIN IMMUN IMMONOPAT, V76, P82
[6]  
KUPER CF, 1992, IMMUNOL TODAY, V13, P219
[7]   INDUCTION OF MUCOSAL AND SYSTEMIC IMMUNITY TO A RECOMBINANT SIMIAN IMMUNODEFICIENCY VIRAL PROTEIN [J].
LEHNER, T ;
BERGMEIER, LA ;
PANAGIOTIDI, C ;
TAO, L ;
BROOKES, R ;
KLAVINSKIS, LS ;
WALKER, P ;
WALKER, J ;
WARD, RG ;
HUSSAIN, L ;
GEARING, AJH ;
ADAMS, SE .
SCIENCE, 1992, 258 (5086) :1365-1369
[8]  
MAZENEC MB, 1992, P NATL ACAD SCI USA, V89, P6901
[9]  
MCDERMOTT MR, 1979, J IMMUNOL, V122, P1892
[10]   THE MUCOSAL IMMUNE-SYSTEM - FROM FUNDAMENTAL-CONCEPTS TO VACCINE DEVELOPMENT [J].
MCGHEE, JR ;
MESTECKY, J ;
DERTZBAUGH, MT ;
ELDRIDGE, JH ;
HIRASAWA, M ;
KIYONO, H .
VACCINE, 1992, 10 (02) :75-88